MedRhythms Advances Pipeline of Neurologic Rehabilitation Products in Multiple Sclerosis, Parkinson's Disease - Maine Technology Institute

MedRhythms Advances Pipeline of Neurologic Rehabilitation Products in Multiple Sclerosis, Parkinson’s Disease

(Reprint from CISION PR Newswire 1/14/2020) PORTLAND, MaineJan. 14, 2020 /PRNewswire/ — MedRhythms, a Portland, Maine-based digital therapeutics company that uses sensors, software, and music to measure and improve walking, today announced the advancement of its pipeline in multiple sclerosis (MS) and Parkinson’s disease (PD). Read more aqui.


Categories:

© 2025 Maine Technology Institute. Todos os direitos reservados. Privacidade

pt_PTPortuguese